An affordable HIV regimen

Althaus, Frances
June 1998
International Family Planning Perspectives;Jun98, Vol. 24 Issue 2, p54
Academic Journal
Reports on the use of the antiretroviral drug zidovudine for HIV-infected pregnant women to lower the rate of perinatal HIV transmission from mother to infant. Feasibility of the regimen for implementation in developing countries.


Related Articles

  • If you're positive, take AZT.  // Joe Weider's Muscle & Fitness;May95, Vol. 56 Issue 5, p48 

    Reports that AZT drug therapy can reduce the risk for mother-to-child HIV transmission. Legal and ethical concerns of AZT drug therapy.

  • Short-course zidovudine in perinatal HIV transmission.  // WHO Drug Information;1999, Vol. 13 Issue 1, p6 

    Reports on clinical trials of short-course zidovudine use in perinatal human immunodeficiency virus (HIV) transmission. Reduction of the risk of transmission; Need to identify HIV infected women who do not receive zidovudine during pregnancy.

  • DECLINE IN VERTICAL TRANSMISSION.  // AIDS Patient Care & STDs;Nov2000, Vol. 14 Issue 11, p615 

    Reports on the decline in the vertical transmission rates of HIV in the United States. Rate decline from 1990 to 1997; Role of the routine use of azidothymidine in HIV-infected pregnant women in the decline.

  • Short-course zidovudine in perinatal HIV transmission: more evidence and debate.  // WHO Drug Information;1999, Vol. 13 Issue 2, p65 

    Describes the use of short-course zidovudine in perinatal HIV transmission. Role of elective cesarean section in prevention of HIV transmission; Efficacy of zidovudine in breast-feeding women; Difficulties in HIV counselling and testing and drug management during labor.

  • Successful Implementation of Perinatal HIV Prevention Guidelines. Wortley, Pascale M.; Lindegren, Mary Lou; Fleming, Patricia L. // MMWR: Morbidity & Mortality Weekly Report;5/11/2001Supplement RR-6, Vol. 50 Issue 18, p15 

    Presents information on a study which evaluated the implementation of guidelines regarding the use of zidovudine to reduce perinatal transmission of the human immunodeficiency virus. Methodology of the study; Results and discussion on the study; Conclusion.

  • Cost-Effective HIV Prevention. Althaus, Frances // International Family Planning Perspectives;Sep98, Vol. 24 Issue 3, p102 

    Reports on a cost-effective HIV prevention measure proposed for Sub-Saharan Africa. Prevention of perinatal transmission of the virus from mother to child through a short course of zidovudine given to pregnant, HIV-infected women; Cost analysis.

  • Using 3'-azido-2',3'-dideoxythymidine (AZT) to prevent perinatal human immunodeficiency virus... Reggy, Atieno A.; Rogers, Martha F. // JNCI: Journal of the National Cancer Institute;11/05/97, Vol. 89 Issue 21, p1566 

    Editorial. Examines the effectiveness of zidovudine in preventing the transmission of perinatal HIV and risk of transplacental carcinogenesis. Relative safety in the use of the drug; Decline in the estimated overall annual incidence of HIV pediatric cases; Unknown long-term effects of the AZT...

  • Zidovudine and maternal HIV transmission.  // American Family Physician;7/1/1994, Vol. 50 Issue 1, p218 

    Reports that zidovudine is effective in the prevention of perinatal transmission of HIV. Protocol of the AIDS Clinical Trials Group (ACTG); Factors associated with zidovudine therapy; Patients eligible for the study.

  • AZT reduces maternal HIV transmission rate.  // Public Health Reports;Sep/Oct94, Vol. 109 Issue 5, p718 

    Reports preliminary results of a collaborative study supported by the National Institute of Child Health and Human Development, the National Institute of Allergy and Infectious Diseases and two French biomedical research agencies which suggest that zidovudine therapy (AZT) reduced by two-thirds...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics